Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
19 April 2024
| m 23:55 | Urothelial carcinoma diffhist 0 Jwarner talk contribs | ||||
|
|
m 23:50 | Melanoma 2 changes history +6 [Jwarner (2×)] | |||
| m |
|
23:50 (cur | prev) +3 Jwarner talk contribs →Regimen variant #1, 2 mg/kg q3wk {{#subobject:25a9fe|Variant=1}} | |||
| m |
|
23:49 (cur | prev) +3 Jwarner talk contribs →Regimen variant #2, indefinite {{#subobject:722e51|Variant=1}} | |||
|
|
m 12:32 | Head and neck cancer 3 changes history +1,820 [Jwarner (3×)] | |||
| m |
|
12:32 (cur | prev) +594 Jwarner talk contribs →Methotrexate monotherapy {{#subobject:0e90b2|Regimen=1}} | |||
| m |
|
12:25 (cur | prev) +293 Jwarner talk contribs →Cetuximab monotherapy {{#subobject:4b973b|Regimen=1}} | |||
| m |
|
12:24 (cur | prev) +933 Jwarner talk contribs →Docetaxel monotherapy {{#subobject:623c3f|Regimen=1}} | |||
|
|
m 00:36 | Esophageal squamous cell carcinoma 3 changes history +27 [Jwarner (3×)] | |||
| m |
|
00:36 (cur | prev) -1 Jwarner talk contribs →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}} | |||
| m |
|
00:35 (cur | prev) -1 Jwarner talk contribs →Regimen {{#subobject:d1dde0|Variant=1}} | |||
| m |
|
00:35 (cur | prev) +29 Jwarner talk contribs →Camrelizumab monotherapy {{#subobject:c701c3|Regimen=1}} | |||
| m 00:29 | Non-small cell lung cancer, nonsquamous diffhist -39 Jwarner talk contribs →Regimen variant #2, 5/500 x 4, then maintenance pem x 2y {{#subobject:1mwjm3|Variant=1}} | ||||
14 April 2024
| m 17:35 | Urothelial carcinoma diffhist -13 Jwarner talk contribs →Preceding treatment | ||||
| m 17:33 | Testicular cancer diffhist +9 Jwarner talk contribs →Regimen variant #5, 45/500/100 (modified BEP) {{#subobject:fd61db|Variant=1}} | ||||
|
|
m 17:29 | Non-small cell lung cancer, nonsquamous 2 changes history +78 [Jwarner (2×)] | |||
| m |
|
17:29 (cur | prev) +45 Jwarner talk contribs →Maintenance after first-line therapy | |||
| m |
|
17:28 (cur | prev) +33 Jwarner talk contribs →Consolidation after definitive therapy for inoperable disease | |||
| m 12:43 | Diffuse large B-cell lymphoma diffhist +355 Jwarner talk contribs | ||||
13 April 2024
|
|
m 15:14 | Esophageal cancer 2 changes history +21 [Jwarner (2×)] | |||
| m |
|
15:14 (cur | prev) +10 Jwarner talk contribs →Definitive therapy | |||
| m |
|
15:13 (cur | prev) +11 Jwarner talk contribs →Preceding treatment | |||
|
|
m 15:12 | Diffuse large B-cell lymphoma 5 changes history +574 [Jwarner (5×)] | |||
| m |
|
15:12 (cur | prev) +1 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:e4284f|Regimen=1}} | |||
| m |
|
15:11 (cur | prev) +230 Jwarner talk contribs →Relapsed or refractory, salvage therapy | |||
| m |
|
15:06 (cur | prev) +61 Jwarner talk contribs | |||
| m |
|
15:04 (cur | prev) +65 Jwarner talk contribs →Maintenance after upfront therapy | |||
| m |
|
15:03 (cur | prev) +217 Jwarner talk contribs →Consolidation after upfront therapy | |||